Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Angion Biomedica Corp.

    NASDAQ: ANGN · Real-Time Price · USD
    1.00
    0.00 (0.00%)
    At close: Jun 01, 2023, 10:00 PM

    Angion Biomedica Statistics

    Share Statistics

    Angion Biomedica has 30.11M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 30.11M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 20.9M

    Failed to Deliver (FTD) Shares

    n/a
    		 178

    FTD / Avg. Volume

    n/a
    		 1.82%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Angion Biomedica.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    Current Ratio

    n/a
    		 0

    Quick Ratio

    n/a
    		 0

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.18

    Debt / FCF

    n/a
    		 -0.11

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $767,000

    Profits Per Employee

    n/a
    		 $-18,566,666.67

    Employee Count

    n/a
    		 3

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 16.89M

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0.6, so Angion Biomedica's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.6

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0.71

    200-Day Moving Average

    n/a
    		 0.82

    Relative Strength Index (RSI)

    n/a
    		 71.81

    Average Volume (20 Days)

    n/a
    		 9,772

    Income Statement

    In the last 12 months, Angion Biomedica had revenue of 2.3M and earned -55.7M in profits. Earnings per share was -1.85.

    Revenue

    n/a
    		 2.3M

    Gross Profit

    n/a
    		 2.3M

    Operating Income

    n/a
    		 -30.44M

    Net Income

    n/a
    		 -55.7M

    EBITDA

    n/a
    		 -20.12M

    EBIT

    n/a
    		 -28.82M

    Earnings Per Share (EPS)

    n/a
    		 -1.85
    Full Income Statement

    Balance Sheet

    The company has 50.49M in cash and 3.71M in debt, giving a net cash position of 46.78M.

    Cash & Cash Equivalents

    n/a
    		 50.49M

    Total Debt

    n/a
    		 3.71M

    Net Cash

    n/a
    		 46.78M

    Retained Earnings

    n/a
    		 -253.94M

    Total Assets

    n/a
    		 30.99M

    Working Capital

    n/a
    		 8.45M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -32.69M and capital expenditures -66K, giving a free cash flow of -32.76M.

    Operating Cash Flow

    n/a
    		 -32.69M

    Capital Expenditures

    n/a
    		 -66K

    Free Cash Flow

    n/a
    		 -32.76M

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 -1322.73%

    FCF Margin

    n/a
    		 -1423.73%

    Dividends & Yields

    ANGN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ANGN.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 2, 2023. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jun 2, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -7.9

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist